Macrophage diversity in cardiac inflammation: A review

Immunobiology

Volumn 217, Issue 5, 2012, Pages 468-475

  Barin, Jobert G ^a,b   Rose, Noel R ^a,b   Čiháková, Daniela ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Autoimmunity; Macrophage; Monocyte; Myocarditis

Indexed keywords

CD16 ANTIGEN; CD32 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 4; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL INTERACTION; CELL LINEAGE; COXSACKIE VIRUS B3; DISEASE MODEL; ENTEROVIRUS; HOST RESISTANCE; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS MYOCARDITIS;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; MACROPHAGES; MONOCYTES; MYOCARDITIS; NEOPLASMS; T-LYMPHOCYTES;

EID: 84858796712     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.06.009     Document Type: Review

References (117)

1. Abramson S.L., Gallin J.I. IL-4 inhibits superoxide production by human mononuclear phagocytes. J. Immunol. 1990, 144:625.
2. Adams D.O., Hamilton T.A. The cell biology of macrophage activation. Annu. Rev. Immunol. 1984, 2:283.
3. Afanasyeva M., Georgakopoulos D., Belardi D.F., Ramsundar A.C., Barin J.G., Kass D.A., Rose N.R. Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function. Am. J. Pathol. 2004, 164:807.
4. Afanasyeva M., Georgakopoulos D., Rose N.R. Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun. Rev. 2004, 3:476.
5. Aiello S., Noris M., Piccinini G., Tomasoni S., Casiraghi F., Bonazzola S., Mister M., Sayegh M.H., Remuzzi G. Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigens. J. Immunol. 2000, 164:4649.
6. Alatery A., Siddiqui S., Chan M., Kus A., Petrof E.O., Basta S. Cross, but not direct, presentation of cell-associated virus antigens by spleen macrophages is influenced by their differentiation state. Immunol. Cell Biol. 2010, 88:3.
7. Al-Omaishi J., Bashir R., Gendelman H.E. The cellular immunology of multiple sclerosis. J. Leukocyte Biol. 1999, 65:444.
8. Anderson C.F., Mosser D.M. Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors. J. Immunol. 2002, 168:3697.
9. Andreoletti L., Leveque N., Boulagnon C., Brasselet C., Fornes P. Viral causes of human myocarditis. Arch. Cardiovasc. Dis. 2009, 102:559.
10. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 2009, 27:669.
11. Barin J.G., Talor M.V., Baldeviano G.C., Kimura M., Rose N.R., Cihakova D. Mechanisms of IFNgamma regulation of autoimmune myocarditis. Exp. Mol. Pathol. 2010.
12. Bingle L., Brown N.J., Lewis C.E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 2002, 196:254.
13. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889.
14. Bloom B.R., Bennett B. Macrophages and delayed-type hypersensitivity. Semin. Hematol. 1970, 7:215.
15. Burgdorf S., Kautz A., Bohnert V., Knolle P.A., Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007, 316:612.
16. Campbell I.K., Rich M.J., Bischof R.J., Dunn A.R., Grail D., Hamilton J.A. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 1998, 161:3639.
17. Campbell I.K., Rich M.J., Bischof R.J., Hamilton J.A. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J. Leukocyte Biol. 2000, 68:144.
18. Cihakova D., Sharma R.B., Fairweather D., Afanasyeva M., Rose N.R. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol. Med. 2004, 102:175.
19. Cihakova D., Barin J.G., Afanasyeva M., Kimura M., Fairweather D., Berg M., Talor M.V., Baldeviano G.C., Frisancho S., Gabrielson K., Bedja D., Rose N.R. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am. J. Pathol. 2008, 172:1195.
20. Cimarelli A. Journey to the heart of macrophages: the delicate relationship between HIV-1 and a multifaceted cell type. Retrovirology 2010, 7:28.
21. Cioc A.M., Nuovo G.J. Histologic and in situ viral findings in the myocardium in cases of sudden, unexpected death. Mod. Pathol. 2002, 15:914.
22. Cooper L.T. Myocarditis. N. Engl. J. Med. 2009, 360:1526.
23. Dagkalis A., Wallace C., Xu H., Liebau S., Manivannan A., Stone M.A., Mack M., Liversidge J., Crane I.J. Development of experimental autoimmune uveitis: efficient recruitment of monocytes is independent of CCR2. Invest. Ophthalmol. Vis. Sci. 2009, 50:4288.
24. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993, 259:1739.
25. David J.R. Lymphocyte mediators and cellular hypersensitivity. N. Engl. J. Med. 1973, 288:143.
26. Eckart R.E., Scoville S.L., Campbell C.L., Shry E.A., Stajduhar K.C., Potter R.N., Pearse L.A., Virmani R. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann. Intern. Med. 2004, 141:829.
27. Escher F., Modrow S., Sabi T., Kuhl U., Lassner D., Schultheiss H.P., Noutsias M. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy. Med. Sci. Monit. 2008, 14:CR589.
28. Fairweather D., Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J. Autoimmun. 2009.
29. Fairweather D., Kaya Z., Shellam G.R., Lawson C.M., Rose N.R. From infection to autoimmunity. J. Autoimmun. 2001, 16:175.
30. Fairweather D., Frisancho-Kiss S., Rose N.R. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev. Med. Virol. 2005, 15:17.
31. Fairweather D., Frisancho-Kiss S., Njoku D.B., Nyland J.F., Kaya Z., Yusung S.A., Davis S.E., Frisancho J.A., Barrett M.A., Rose N.R. Complement receptor 1 and 2 deficiency increases coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages, IL-1beta, and immune complex deposition in the heart. J. Immunol. 2006, 176:3516.
32. Fleetwood A.J., Lawrence T., Hamilton J.A., Cook A.D. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 2007, 178:5245.
33. Floris S., Blezer E.L., Schreibelt G., Dopp E., van der Pol S.M., Schadee-Eestermans I.L., Nicolay K., Dijkstra C.D., de Vries H.E. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 2004, 127:616.
34. Frisancho-Kiss S., Coronado M.J., Frisancho J.A., Lau V.M., Rose N.R., Klein S.L., Fairweather D. Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav. Immun. 2009, 23:649.
35. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71.
36. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656.
37. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23.
38. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953.
39. Goser S., Ottl R., Brodner A., Dengler T.J., Torzewski J., Egashira K., Rose N.R., Katus H.A., Kaya Z. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 2005, 112:3400.
40. Gratchev A., Kzhyshkowska J., Kothe K., Muller-Molinet I., Kannookadan S., Utikal J., Goerdt S. Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology 2006, 211:473.
41. Hu X., Ivashkiv L.B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009, 31:539.
42. Hume D.A. Macrophages as APC and the dendritic cell myth. J. Immunol. 2008, 181:5829.
43. Ishiyama S., Hiroe M., Nishikawa T., Abe S., Shimojo T., Ito H., Ozasa S., Yamakawa K., Matsuzaki M., Mohammed M.U., Nakazawa H., Kasajima T., Marumo F. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation 1997, 95:489.
44. Kai H., Kudo H., Takayama N., Yasuoka S., Kajimoto H., Imaizumi T. Large blood pressure variability and hypertensive cardiac remodeling - role of cardiac inflammation. Circ. J. 2009, 73:2198.
45. Kallwellis-Opara A., Dorner A., Poller W.C., Noutsias M., Kuhl U., Schultheiss H.P., Pauschinger M. Autoimmunological features in inflammatory cardiomyopathy. Clin. Res. Cardiol. 2007, 96:469.
46. Kania G., Blyszczuk P., Valaperti A., Dieterle T., Leimenstoll B., Dirnhofer S., Zulewski H., Eriksson U. Prominin-1+/CD133+ bone marrow-derived heart-resident cells suppress experimental autoimmune myocarditis. Cardiovasc. Res. 2008, 80:236.
47. Kania G., Blyszczuk P., Stein S., Valaperti A., Germano D., Dirnhofer S., Hunziker L., Matter C.M., Eriksson U. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circ. Res. 2009, 105:462.
48. Kay D.G., Yue P., Hanna Z., Jothy S., Tremblay E., Jolicoeur P. Cardiac disease in transgenic mice expressing human immunodeficiency virus-1 nef in cells of the immune system. Am. J. Pathol. 2002, 161:321.
49. Kelchtermans H., Schurgers E., Geboes L., Mitera T., Van Damme J., Van Snick J., Uyttenhove C., Matthys P. Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma. Arthritis Res. Ther. 2009, 11:R122.
50. Kemeny E., Grieve T., Marcus R., Sareli P., Zabriskie J.B. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin. Immunol. Immunopathol. 1989, 52:225.
51. Kiesel J.R., Buchwald Z.S., Aurora R. Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. J. Immunol. 2009, 182:5477.
52. King I.L., Dickendesher T.L., Segal B.M. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009, 113:3190.
53. Kleinschmidt W.J., Schultz R.M. Similarities of murine gamma interferon and the lymphokine that renders macrophages cytotoxic. J. Interferon Res. 1982, 2:291.
54. Kryczek I., Zou L., Rodriguez P., Zhu G., Wei S., Mottram P., Brumlik M., Cheng P., Curiel T., Myers L., Lackner A., Alvarez X., Ochoa A., Chen L., Zou W. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J. Exp. Med. 2006, 203:871.
55. Kuethe F., Lindner J., Matschke K., Wenzel J.J., Norja P., Ploetze K., Schaal S., Kamvissi V., Bornstein S.R., Schwanebeck U., Modrow S. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin. Infect. Dis. 2009, 49:1660.
56. Li K., Xu W., Guo Q., Jiang Z., Wang P., Yue Y., Xiong S. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ. Res. 2009, 105:353.
57. Lindner J., Noutsias M., Lassner D., Wenzel J., Schultheiss H.P., Kuehl U., Modrow S. Adaptive immune responses against parvovirus B19 in patients with myocardial disease. J. Clin. Virol. 2009, 44:27.
58. Loke P., MacDonald A.S., Robb A., Maizels R.M., Allen J.E. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur. J. Immunol. 2000, 30:2669.
59. Magnani J.W., Dec G.W. Myocarditis: current trends in diagnosis and treatment. Circulation 2006, 113:876.
60. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23:549.
61. Mantovani A., Sozzani S., Locati M., Schioppa T., Saccani A., Allavena P., Sica A. Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Novartis Found. Symp. 2004, 256:137.
62. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677.
63. Mantovani A., Sica A., Locati M. Macrophage polarization comes of age. Immunity 2005, 23:344.
64. Mantovani A., Schioppa T., Porta C., Allavena P., Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metast. Rev. 2006, 25:315.
65. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 2006, 177:7303.
66. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008, 13:453.
67. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 2009, 27:451.
68. Marusic S., Miyashiro J.S., Douhan J., Konz R.F., Xuan D., Pelker J.W., Ling V., Leonard J.P., Jacobs K.A. Local delivery of granulocyte macrophage colony-stimulating factor by retrovirally transduced antigen-specific T cells leads to severe, chronic experimental autoimmune encephalomyelitis in mice. Neurosci. Lett. 2002, 332:185.
69. McQualter J.L., Darwiche R., Ewing C., Onuki M., Kay T.W., Hamilton J.A., Reid H.H., Bernard C.C. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 2001, 194:873.
70. Melo R.C. Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection. J. Cell. Mol. Med. 2009, 13:279.
71. Menke J., Rabacal W.A., Byrne K.T., Iwata Y., Schwartz M.M., Stanley E.R., Schwarting A., Kelley V.R. Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis. J. Am. Soc. Nephrol. 2009, 20:2581.
72. Metschnikoff E. A disease of Daphnia caused by a yeast. A contribution to the theory of phagocytes as agents for attack on disease-causing organisms. Archiv Pathol Anatomy 1884, 96:177.
73. Mildner A., Mack M., Schmidt H., Bruck W., Djukic M., Zabel M.D., Hille A., Priller J., Prinz M. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain 2009, 132:2487.
74. Montgomery R.R., Booth C.J., Wang X., Blaho V.A., Malawista S.E., Brown C.R. Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis. Infect. Immun. 2007, 75:613.
75. Mosser D.M. The many faces of macrophage activation. J. Leukoc. Biol. 2003, 73:209.
76. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958.
77. Movahedi K., Guilliams M., Van den Bossche J., Van den Bergh R., Gysemans C., Beschin A., De Baetselier P., Van Ginderachter J.A. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008, 111:4233.
78. Mukhopadhyay S., Chen Y., Sankala M., Peiser L., Pikkarainen T., Kraal G., Tryggvason K., Gordon S. MARCO, an innate activation marker of macrophages, is a class A scavenger receptor for Neisseria meningitidis. Eur. J. Immunol. 2006, 36:940.
79. Munder M., Eichmann K., Moran J.M., Centeno F., Soler G., Modolell M. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 1999, 163:3771.
80. Nahrendorf M., Swirski F.K., Aikawa E., Stangenberg L., Wurdinger T., Figueiredo J.L., Libby P., Weissleder R., Pittet M.J. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 2007, 204:3037.
81. Naito M., Hayashi S., Yoshida H., Nishikawa S., Shultz L.D., Takahashi K. Abnormal differentiation of tissue macrophage populations in 'osteopetrosis' (op) mice defective in the production of macrophage colony-stimulating factor. Am. J. Pathol. 1991, 139:657.
82. Nakayama M., Akiba H., Takeda K., Kojima Y., Hashiguchi M., Azuma M., Yagita H., Okumura K. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 2009, 113:3821.
83. Nathan C.F., Murray H.W., Wiebe M.E., Rubin B.Y. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 1983, 158:670.
84. Ojalvo L.S., King W., Cox D., Pollard J.W. High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. Am. J. Pathol. 2009, 174:1048.
85. Perrier P., Martinez F.O., Locati M., Bianchi G., Nebuloni M., Vago G., Bazzoni F., Sozzani S., Allavena P., Mantovani A. Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13. J. Immunol. 2004, 172:7031.
86. Plater-Zyberk C., Joosten L.A., Helsen M.M., Koenders M.I., Baeuerle P.A., van den Berg W.B. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model. Ann. Rheum. Dis. 2009, 68:721.
87. Poffenberger M.C., Straka N., El Warry N., Fang D., Shanina I., Horwitz M.S. Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis. PLoS One 2009, 4:e6207.
88. Pollard J.W. Trophic macrophages in development and disease. Nat. Rev. Immunol. 2009, 9:259.
89. Ponomarev E.D., Shriver L.P., Maresz K., Pedras-Vasconcelos J., Verthelyi D., Dittel B.N. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J. Immunol. 2007, 178:39.
90. Powell T.J., Jenkins C.D., Hattori R., MacPherson G.G. Rat bone marrow-derived dendritic cells, but not ex vivo dendritic cells, secrete nitric oxide and can inhibit T-cell proliferation. Immunology 2003, 109:197.
91. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39.
92. Qureshi A.A., Hosoi J., Xu S., Takashima A., Granstein R.D., Lerner E.A. Langerhans cells express inducible nitric oxide synthase and produce nitric oxide. J. Invest. Dermatol. 1996, 107:815.
93. Reddy P.H., Manczak M., Zhao W., Nakamura K., Bebbington C., Yarranton G., Mao P. Granulocyte-macrophage colony-stimulating factor antibody suppresses microglial activity: implications for anti-inflammatory effects in Alzheimer's disease and multiple sclerosis. J. Neurochem. 2009, 111:1514.
94. Roberts W.K., Vasil A. Evidence for the identity of murine gamma interferon and macrophage activating factor. J. Interferon Res. 1982, 2:519.
95. Rose N.R. Viral damage or 'molecular mimicry'-placing the blame in myocarditis. Nat. Med. 2000, 6:631.
96. Rose N.R. Myocarditis: infection versus autoimmunity. J. Clin. Immunol. 2009, 29:730.
97. Rose N.R., Herskowitz A., Neumann D.A., Neu N. Autoimmune myocarditis: a paradigm of post-infection autoimmune disease. Immunol. Today 1988, 9:117.
98. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59.
99. Shin T., Tanuma N., Kim S., Jin J., Moon C., Kim K., Kohyama K., Matsumoto Y., Hyun B. An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rats. J. Neuroimmunol. 1998, 92:133.
100. Smith S.C., Allen P.M. Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 1991, 147:2141.
101. Smith S.C., Allen P.M. The role of T cells in myosin-induced autoimmune myocarditis. Clin. Immunol. Immunopathol. 1993, 68:100.
102. Sonderegger I., Iezzi G., Maier R., Schmitz N., Kurrer M., Kopf M. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 2008, 205:2281.
103. Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 1992, 176:287.
104. Suda T., Tanaka S., Takahashi N. Macrophage colon-stimulating factor (M-CSF) is essential for differentiation rather than proliferation of osteoclast progenitors. Osteoporosis Int. 1993, 3(Suppl. 1):111.
105. Sun J., Li S.H., Liu S.M., Wu J., Weisel R.D., Zhuo Y.F., Yau T.M., Li R.K., Fazel S.S. Improvement in cardiac function after bone marrow cell thearpy is associated with an increase in myocardial inflammation. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H43.
106. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., Figueiredo J.L., Kohler R.H., Chudnovskiy A., Waterman P., Aikawa E., Mempel T.R., Libby P., Weissleder R., Pittet M.J. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612.
107. Takahashi K. Development and differentiation of macrophages and related cells: historical review and current concepts. J. Clin. Exp. Hematopathol. 2001, 41:1.
108. Tam P.E. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol. 2006, 19:133.
109. Tanaka S., Takahashi N., Udagawa N., Tamura T., Akatsu T., Stanley E.R., Kurokawa T., Suda T. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J. Clin. Invest. 1993, 91:257.
110. Valaperti A., Marty R.R., Kania G., Germano D., Mauermann N., Dirnhofer S., Leimenstoll B., Blyszczuk P., Dong C., Mueller C., Hunziker L., Eriksson U. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J. Immunol. 2008, 180:2686.
111. van Furth R., Cohn Z.A., Hirsch J.G., Humphrey J.H., Spector W.G., Langevoort H.L. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull. World Health Organ. 1972, 46:845.
112. Villacorta-Lyew R., Laselle B., Mazzoncini J.P., Merchant E., Buckley P.J. Cardiac pathological conditions in young soldiers: case series. Mil. Med. 2008, 173:1122.
113. Welch J.S., Escoubet-Lozach L., Sykes D.B., Liddiard K., Greaves D.R., Glass C.K. TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J. Biol. Chem. 2002, 277:42821.
114. Woollard K.J., Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 2010, 7:77.
115. Wu C.Y., Feng Y., Qian G.C., Wu J.H., Luo J., Wang Y., Chen G.J., Guo X.K., Wang Z.J. alpha-Galactosylceramide protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Clin. Exp. Immunol. 2010.
116. Yearley J.H., Pearson C., Carville A., Shannon R.P., Mansfield K.G. SIV-associated myocarditis: viral and cellular correlates of inflammation severity. AIDS Res. Hum. Retrov. 2006, 22:529.
117. Yoshida H., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okamura H., Sudo T., Shultz L.D. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990, 345:442.